Rocket Pharmaceuticals (RCKT) Interest Coverage Ratio (2016 - 2025)
Historic Interest Coverage Ratio for Rocket Pharmaceuticals (RCKT) over the last 9 years, with Q3 2025 value amounting to 110.46.
- Rocket Pharmaceuticals' Interest Coverage Ratio rose 2506.04% to 110.46 in Q3 2025 from the same period last year, while for Sep 2025 it was 132.46, marking a year-over-year increase of 890.16%. This contributed to the annual value of 144.86 for FY2024, which is 460.32% down from last year.
- As of Q3 2025, Rocket Pharmaceuticals' Interest Coverage Ratio stood at 110.46, which was up 2506.04% from 150.42 recorded in Q2 2025.
- In the past 5 years, Rocket Pharmaceuticals' Interest Coverage Ratio registered a high of 22.68 during Q1 2021, and its lowest value of 156.5 during Q2 2024.
- Over the past 5 years, Rocket Pharmaceuticals' median Interest Coverage Ratio value was 134.64 (recorded in 2023), while the average stood at 124.2.
- Per our database at Business Quant, Rocket Pharmaceuticals' Interest Coverage Ratio crashed by 92835.36% in 2021 and then skyrocketed by 2506.04% in 2025.
- Quarter analysis of 5 years shows Rocket Pharmaceuticals' Interest Coverage Ratio stood at 95.75 in 2021, then tumbled by 54.49% to 147.93 in 2022, then increased by 8.98% to 134.64 in 2023, then grew by 1.55% to 132.55 in 2024, then rose by 16.66% to 110.46 in 2025.
- Its last three reported values are 110.46 in Q3 2025, 150.42 for Q2 2025, and 136.42 during Q1 2025.